FindMyRecallSubscribe
Class I: serious health riskTerminated

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) Hydrocodone Bitartrate and Acetaminophen Recall

Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · Rockford, IL

Risk level
Class I
Reported by FDA
Feb 27, 2013
Recall ID
D-166-2013
Check your lot numberHow we source this data

Summary

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalled Hydrocodone Bitartrate and Acetaminophen starting Dec 14, 2012. The FDA classified it as Class I (serious health risk) and published enforcement report D-166-2013 on Feb 27, 2013. Reason: Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components. Status: Terminated.

Why it was recalled

Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.

Product description

Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 blistered tablets per carton, Rx only; Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, Pkg by & Distributed by UDL Laboratories, Inc., Rockford, IL 61103; NDC 51079-254-21.

Lot numbers, UPCs & expiration codes

Lot #: 3037841, 3040859, 3042573, Exp 12/13

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-166-2013
Classification
Class I
Status
Terminated
Recall initiated
Dec 14, 2012
FDA report date
Feb 27, 2013
Quantity
3,407 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Original FDA data

Every field from FDA enforcement report D-166-2013, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
63899
Address
1718 Northrock Ct
Code information
Lot #: 3037841, 3040859, 3042573, Exp 12/13
Postal code
61103-1201
Report date
Feb 27, 2013
Product type
Drugs
Recall number
D-166-2013
Classification
Class I
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Product quantity
3,407 cartons
Termination date
Aug 9, 2016
Reason for recall
Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 blistered tablets per carton, Rx only; Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, Pkg by & Distributed by UDL Laboratories, Inc., Rockford, IL 61103; NDC 51079-254-21.
Distribution pattern
Nationwide
Recall initiation date
Dec 14, 2012
Initial firm notification
Letter
Center classification date
Feb 15, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-166-2013, published Feb 27, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls